APA (7th ed.) Citation

Adam, C. M., Wetzel, T. J., Erfan, S. C., Wheeler, L. M., Baer, E. E., Croll, L. P., . . . Ananieva, E. A. (2026). Blocking mitochondrial leucine transamination enhances T-cell activation and improves T-cell immunity against OVA-producing EL4 lymphoma. British Journal of Cancer, 135(3), 406. https://doi.org/10.1038/s41416-026-03455-5

Chicago Style (17th ed.) Citation

Adam, Christie M., et al. "Blocking Mitochondrial Leucine Transamination Enhances T-cell Activation and Improves T-cell Immunity Against OVA-producing EL4 Lymphoma." British Journal of Cancer 135, no. 3 (2026): 406. https://doi.org/10.1038/s41416-026-03455-5.

MLA (9th ed.) Citation

Adam, Christie M., et al. "Blocking Mitochondrial Leucine Transamination Enhances T-cell Activation and Improves T-cell Immunity Against OVA-producing EL4 Lymphoma." British Journal of Cancer, vol. 135, no. 3, 2026, p. 406, https://doi.org/10.1038/s41416-026-03455-5.